TD Cowen Reiterates Buy Rating on Cellebrite (CLBT)

May 24, 2024 8:41 AM EDT Send to a Friend
TD Cowen analyst Shaul Eyal reiterated a Buy rating and $15.00 price target on Cellebrite (NASDAQ: CLBT),The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login